City of Hope Opens Phase 1 Clinical Trial Aiming to One Day Transform Rectal Cancer Into a Disease Treatable With Radiation Therapy to Avoid Potential Long-Term Side Effects of Surgery
March 26, 2025
March 26, 2025
DUARTE, California, March 26 -- City of Hope issued the following news release:
* * *
City of Hope opens phase 1 clinical trial aiming to one day transform rectal cancer into a disease treatable with radiation therapy to avoid potential long-term side effects of surgery
Physician scientists will evaluate an alternative use of an investigational enzyme inhibitor, papaverine, which is hypothesized to prime regions of tumors to be more susceptible to radiation . . .
* * *
City of Hope opens phase 1 clinical trial aiming to one day transform rectal cancer into a disease treatable with radiation therapy to avoid potential long-term side effects of surgery
Physician scientists will evaluate an alternative use of an investigational enzyme inhibitor, papaverine, which is hypothesized to prime regions of tumors to be more susceptible to radiation . . .